Pomdoctor Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-130.93	-37.37	-36.95	-19.83	-96.18
Depreciation & Amortization	0.15	0.13	0.11	-	17.68
Stock-Based Compensation	16.42	-	-	-	-
Other Adjustments	3.75	3.57	3.6	-0.77	27.69
Change in Receivables	-68.43	19.68	-5.29	-24.79	-1.72
Changes in Inventories	-1	3.03	-5	-0.08	-1.59
Changes in Accounts Payable	19.47	-16.34	-1.66	12.94	5.43
Changes in Accrued Expenses	3.97	0.07	-3.5	5.3	5.15
Changes in Unearned Revenue	-0.16	0.51	-1.49	1.28	1.45
Changes in Other Operating Activities	8.28	10.58	4.37	3.94	26.43
Operating Cash Flow	-148.48	-16.13	-45.8	-22.02	-15.68
Capital Expenditures	-1.01	-0.04	-0.11	-	-
Sale of Property, Plant & Equipment	-	0	-	-	-
Purchases of Investments	-	-	-	-	-0.5
Other Investing Activities	-0.6	-	-	-	-
Investing Cash Flow	-1.61	-0.03	-0.11	-	-0.5
Short-Term Debt Issued	56	44.1	28	10.1	9
Short-Term Debt Repaid	-37.96	-31.14	-15.66	-1.52	-17.86
Net Short-Term Debt Issued (Repaid)	18.04	12.96	12.34	8.57	-8.86
Long-Term Debt Issued	34.73	41.16	108.55	25.33	54.42
Long-Term Debt Repaid	-38.71	-37.1	-68.55	-11.41	-40.13
Net Long-Term Debt Issued (Repaid)	-3.98	4.06	40.01	13.92	14.3
Issuance of Common Stock	163.93	-	-	-	-
Net Common Stock Issued (Repurchased)	163.93	-	-	-	-
Other Financing Activities	-24.06	-	-2.28	-	-
Financing Cash Flow	153.93	17.02	50.07	22.49	5.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1.91	-0.01	-	-	-
Net Cash Flow	1.93	0.85	4.16	0.47	-10.74
Free Cash Flow	-149.49	-16.17	-45.91	-22.02	-15.68
FCF Margin	-37.38%	-4.72%	-15.06%	-8.98%	-7.28%
Free Cash Flow Per Share	-2.57	-0.43	-1.21	-0.91	-0.65
Levered Free Cash Flow	-168.82	-128.39	-100.32	-79.64	-128.43
Unlevered Free Cash Flow	-88.93	-27.84	-29.52	19.79	-25.13

SEC Filings: 10-K · 10-Q